focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison reviews Aberdeen Latin American Income Fund

27 Feb 2020 17:38

RNS Number : 4140E
Aberdeen Latin American Inc Fd Ltd
27 February 2020
 

 

London, UK, 27 February 2020

Edison reviews Aberdeen Latin American Income Fund (ALAI)

Aberdeen Latin American Income Fund (ALAI) offers exposure to Latin American equities and government debt. It is managed by Aberdeen Standard Investments' (ASI's) global emerging markets equities and emerging market debt teams. While 2019 was a difficult year in terms of economic growth, the markets performed strongly, underlining the resilience of the region. The managers remain 'cautiously optimistic' on the outlook for Latin America, led by the largest economies Brazil and Mexico, which are supported by lower interest rates and stable inflation, while there is also a positive government reform agenda in Brazil. ALAI is continuing to deliver on its income objective without compromising on its capital growth potential. It has meaningful revenue reserves and the fund offers an attractive 5.1% yield.

 

ALAI's discount remains persistently wide, typically within a 10-16% range over the last three years. There is scope for an improved valuation if there is increased investor demand for exposure to Latin America. The current 12.5% discount to cum-income NAV compares to the 12.6% to 13.5% range of average discounts over the last one, three and five years. ALAI has paid a 3.5p per share annual dividend in each of the last four financial years and offers a 5.1% yield.

Click here to view the full report.

 

Subscribe to Edison's content to receive reports by email.

All reports published by Edison are free-to-access and available on the website.

 

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Sarah Godfrey, +44 (0)20 3681 2519

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group- 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAFLFVDFSIDFII
Date   Source Headline
16th Feb 20221:04 pmRNSNet Asset Value(s)
15th Feb 202212:42 pmRNSNet Asset Value(s)
14th Feb 20224:06 pmRNSPortfolio disclosure
14th Feb 20222:12 pmRNSGearing disclosure
14th Feb 20221:04 pmRNSNet Asset Value(s)
11th Feb 202212:29 pmRNSNet Asset Value(s)
10th Feb 202211:18 amRNSNet Asset Value(s)
9th Feb 202211:10 amRNSNet Asset Value(s)
8th Feb 202211:19 amRNSNet Asset Value(s)
7th Feb 20221:22 pmRNSGearing disclosure
7th Feb 202212:20 pmRNSNet Asset Value(s)
7th Feb 202210:40 amRNSMonth End Net Asset Value(s)
4th Feb 20222:51 pmRNSNet Asset Value(s)
3rd Feb 202211:20 amRNSNet Asset Value(s)
2nd Feb 202212:45 pmRNSNet Asset Value(s)
31st Jan 20223:45 pmRNSGearing disclosure
31st Jan 202212:50 pmRNSNet Asset Value(s)
28th Jan 202212:17 pmRNSNet Asset Value(s)
27th Jan 202211:29 amRNSNet Asset Value(s)
26th Jan 202211:52 amRNSNet Asset Value(s)
25th Jan 202211:52 amRNSNet Asset Value(s)
24th Jan 20222:51 pmRNSGearing disclosure
24th Jan 202211:40 amRNSNet Asset Value(s)
21st Jan 20221:19 pmRNSNet Asset Value(s)
20th Jan 20225:11 pmRNSHolding(s) in Company
20th Jan 202211:59 amRNSNet Asset Value(s)
19th Jan 202211:42 amRNSNet Asset Value(s)
18th Jan 202212:23 pmRNSNet Asset Value(s)
17th Jan 20224:27 pmRNSGearing disclosure
17th Jan 202212:14 pmRNSNet Asset Value(s)
17th Jan 202211:35 amRNSPortfolio disclosure
14th Jan 202210:26 amRNSNet Asset Value(s)
13th Jan 202211:36 amRNSNet Asset Value(s)
12th Jan 202212:08 pmRNSNet Asset Value(s)
11th Jan 20222:34 pmRNSCompany name change and Directorate change
11th Jan 202212:05 pmRNSNet Asset Value(s)
11th Jan 202210:38 amRNSMonth End Net Asset Value(s)
10th Jan 20221:21 pmRNSGearing disclosure
10th Jan 202211:24 amRNSNet Asset Value(s)
7th Jan 202210:24 amRNSNet Asset Value(s)
6th Jan 202210:59 amRNSNet Asset Value(s)
5th Jan 202212:10 pmRNSNet Asset Value(s)
4th Jan 20224:30 pmRNSGearing disclosure
31st Dec 202112:22 pmRNSNet Asset Value(s)
30th Dec 202111:31 amRNSNet Asset Value(s)
29th Dec 20213:20 pmRNSGearing disclosure
29th Dec 202111:29 amRNSNet Asset Value(s)
24th Dec 202111:20 amRNSNet Asset Value(s)
23rd Dec 202112:49 pmRNSNet Asset Value(s)
22nd Dec 202111:49 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.